proisback (42.34) Submitted: 9/23/2009 6:19:31 PM : Start Price: $2.88 EXAS Score: +231.41

There are currently no analysts covering EXAS, but in a few months there will be BUY recs by a few sell side analysts. These BUY recs will bring in institutional buyers which will drive the stock price up dramatically. There will be new health legislation that will pay for routine screening without co-pays. EXAS is developing the best non invasive FDA approved test now. The time to BUY is before the large institutions hear about EXAS from the sell side analysts.